Literature DB >> 23157418

Binding selectivity studies of phosphoinositide 3-kinases using free energy calculations.

Dima A Sabbah1, Jonathan L Vennerstrom, Haizhen A Zhong.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) and their phosphatidylinositol 3,4,5-triphosphate (PIP(3)) products regulate a variety of cellular processes. Of these, PI3Kα is an attractive target for anticancer drug design. Mutations in the PI3Kα kinase domain alter the mobility of the activation loop resulting in gain of function. We employed molecular dynamics (MD) simulations-based energetic analysis using molecular mechanics/generalized born surface area (MM/GBSA) for PI3Kα and -γ. MD simulations were carried out for PI3K models based on the RESP (restrained electrostatic potential) and quantum mechanics (QM)-polarized ligand docking (QPLD)-derived partial charges. Computational alanine scanning was also used to evaluate the contributions of key binding residues to ligand binding. Our results show that both RESP and QPLD charge models of PI3Kα and PI3Kγ provide similar performance in MD simulations. For example, the predicted RESP and QPLD free energies of -9.5 and -9.3 kcal/mol for LY294002 binding to PI3Kγ and -10.9 and -11.7 kcal/mol for wortmannin binding to PI3Kα are in good agreement with experimental values. A significant loss in binding free energy was observed when hydrophobic residues were mutated to alanine, suggesting that specific hydrophobic interactions are important to optimal ligand binding. MM/GBSA calculations suggested that residues Ser774, Gln859, and Ile932 of PI3Kα might be used to design H1047R mutant-specific ligands, whereas Lys890 of PI3Kγ can be used for ligand design targeting PI3Kγ.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157418     DOI: 10.1021/ci3003057

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  6 in total

1.  Molecular insight into isoform specific inhibition of PI3K-α and PKC-η with dietary agents through an ensemble pharmacophore and docking studies.

Authors:  Baki Vijaya Bhaskar; Aluru Rammohan; Tirumalasetty Munichandra Babu; Gui Yu Zheng; Weibin Chen; Wudayagiri Rajendra; Grigory V Zyryanov; Wei Gu
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

2.  Cholesterol-coated gold nanorods as an efficient nano-carrier for chemotherapeutic delivery and potential treatment of breast cancer: in vitro studies using the MCF-7 cell line.

Authors:  Nouf N Mahmoud; Dima A Sabbah; Rana Abu-Dahab; Duaa Abuarqoub; Maha Abdallah; Ameerah Hasan Ibrahim; Enam A Khalil
Journal:  RSC Adv       Date:  2019-04-24       Impact factor: 4.036

3.  An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity.

Authors:  Rafał Kurczab; Vittorio Canale; Paweł Zajdel; Andrzej J Bojarski
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

4.  Novel amphiphilic pyridinium ionic liquids-supported Schiff bases: ultrasound assisted synthesis, molecular docking and anticancer evaluation.

Authors:  Fawzia Faleh Al-Blewi; Nadjet Rezki; Salsabeel Abdullah Al-Sodies; Sanaa K Bardaweel; Dima A Sabbah; Mouslim Messali; Mohamed Reda Aouad
Journal:  Chem Cent J       Date:  2018-11-22       Impact factor: 4.215

5.  Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms.

Authors:  Jingyu Zhu; Ke Ke; Lei Xu; Jian Jin
Journal:  RSC Adv       Date:  2019-06-28       Impact factor: 4.036

6.  Molecular Modeling, Synthesis and Biological Evaluation of N-Phenyl-4-Hydroxy-6-Methyl-2-Quinolone-3-CarboxAmides as Anticancer Agents.

Authors:  Dima A Sabbah; Shaima' E Hasan; Reema Abu Khalaf; Sanaa K Bardaweel; Rima Hajjo; Khalid M Alqaisi; Kamal A Sweidan; Aya M Al-Zuheiri
Journal:  Molecules       Date:  2020-11-16       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.